Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

Authors: Lanasa, Mark C., Andritsos, Leslie, Brown, Jennifer R., Gabrilove, Janice, Caligaris-Cappio, Federico, Ghia, Paolo, Larson, Richard A., Kipps, Thomas J., Leblond, Veronique, Milligan, Donald W., Janssens, Ann, Johnson, Amy J., Heerema, Nyla A., Bühler, Andreas, Stilgenbauer, Stephan, Devin, Jeanne, Hallek, Michael, Byrd, John C., Grever, Michael R.

Source: In Leukemia Research May 2015 39(5):495-500

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA

Authors: Burnett, Alan K. ^*, Hills, Robert K., Green, Claire, Jenkinson, Sarah, Koo, Kenneth, Patel, Yashma, Guy, Carol, Gilkes, Amanda, Milligan, Donald W., Goldstone, Anthony H., Prentice, Archibald G., Wheatley, Keith, Linch, David C., Gale, Rosemary E.

Source: In Blood 4 February 2010 115(5):948-956

Resistance to Antiviral Drugs in Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients: Risk Factors and Prognostic Significance

Authors: Chakrabarti, Suparno, Pillay, Deenan, Ratcliffe, Daina, Cane, Patricia A., Collingham, Kathryn E., Milligan, Donald W.

Source: The Journal of Infectious Diseases, 2000 Jun 01. 181(6), 2055-2058.

Access URL: https://www.jstor.org/stable/30110364

Rationing Certainly Exists in Treatment for Cancer

Authors: Milligan, Donald W.

Source: BMJ: British Medical Journal, 2000 Mar 01. 320(7236), 717-717.

Access URL: https://www.jstor.org/stable/25187364

Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?

Authors: Delgado, Julio, Milligan, Donald W., Dreger, Peter

Source: In Blood 24 September 2009 114(13):2581-2588

Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial

Authors: Milligan, Donald W. ^*, Wheatley, Keith, Littlewood, Timothy, Craig, Jenny I.O., Burnett, Alan K.

Source: In Blood 15 June 2006 107(12):4614-4622

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

Authors: Delgado, Julio, Thomson, Kirsty, Russell, Nigel, Ewing, Joanne, Stewart, Wendy, Cook, Gordon, Devereux, Stephen, Lovell, Richard, Chopra, Rajesh, Marks, David I., Mackinnon, Stephen, Milligan, Donald W. ^*

Source: In Blood 15 February 2006 107(4):1724-1730

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Authors: Campbell, Peter J, Scott, Linda M, Buck, Georgina, Wheatley, Keith, East, Clare L, Marsden, Joanne T, Duffy, Audrey, Boyd, Elaine M, Bench, Anthony J, Scott, Mike A, Vassiliou, George S, Milligan, Donald W, Smith, Steve R, Erber, Wendy N, Bareford, David, Wilkins, Bridget S, Reilly, John T, Harrison, Claire N, Green, Anthony R

Source: In The Lancet 3-9 December 2005 366(9501):1945-1953

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses

Authors: Milligan, Donald W., Fernandes, Savio, Dasgupta, Ranjit, Davies, Faith E., Matutes, Estella, Fegan, Christopher D., McConkey, Christopher, Child, J. Anthony, Cunningham, David, Morgan, Gareth J., Catovsky, Daniel

Source: In Blood 1 January 2005 105(1):397-404

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Authors: Cook, Mark A. ^*, Milligan, Donald W., Fegan, Christopher D., Darbyshire, Philip J., Mahendra, Premini, Craddock, Charles F., Moss, Paul A.H., Briggs, David C.

Source: In Blood 15 February 2004 103(4):1521-1526

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

Authors: Avivi, Irit, Chakrabarti, Suparno ^*, Milligan, Donald W, Waldmann, H, Hale, Geoff, Osman, Husam, Ward, Katherine N, Fegan, Christopher D, Yong, Kwee, Goldstone, Anthony H, Linch, David C, MacKinnon, Stephen

Source: In Biology of Blood and Marrow Transplantation 2004 10(3):186-194

A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia

Authors: Kell, William J., Burnett, Alan K. ^*, Chopra, Raj, Yin, John A.L., Clark, Richard E., Rohatiner, Ama, Culligan, Dominic, Hunter, Ann, Prentice, Archie G., Milligan, Donald W.

Source: In Blood 15 December 2003 102(13):4277-4283

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

Authors: Marks, David I. ^*, Lush, Richard, Cavenagh, Jamie, Milligan, Donald W., Schey, Steven, Parker, Anne, Clark, Fiona J., Hunt, Linda, Yin, John, Fuller, Steven, Vandenberghe, Elisabeth, Marsh, Judith, Littlewood, Timothy, Smith, Graeme M., Culligan, Dominic, Hunter, Ann, Chopra, Rajesh, Davies, Andrew, Towlson, Keiren, Williams, Catherine D.

Source: In Blood 1 November 2002 100(9):3108-3114

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

Authors: Chakrabarti, Suparno, Mautner, Vivien, Osman, Husam, Collingham, Kathryn E., Fegan, Chris D., Klapper, Paul E., Moss, Paul A.H., Milligan, Donald W.

Source: In Blood 1 September 2002 100(5):1619-1627

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Authors: Chakrabarti, Suparno, Mackinnon, Stephen, Chopra, Raj, Kottaridis, Panagiotis D., Peggs, Karl, O'Gorman, Peter, Chakraverty, Ronjon, Marshall, Timothy, Osman, Husam, Mahendra, Premini, Craddock, Charles, Waldmann, Herman, Hale, Geoff, Fegan, Christopher D., Yong, Kwee, Goldstone, Anthony H., Linch, David C., Milligan, Donald W.

Source: In Blood 15 June 2002 99(12):4357-4363

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Authors: Chakraverty, Ronjon, Peggs, Karl, Chopra, Rajesh, Milligan, Donald W., Kottaridis, Panagiotis D., Verfuerth, Stephanie, Geary, Johanne, Thuraisundaram, Dharsha, Branson, Kate, Chakrabarti, Suparno, Mahendra, Premini, Craddock, Charles, Parker, Anne, Hunter, Ann, Hale, Geoff, Waldmann, Herman, Williams, Catherine D., Yong, Kwee, Linch, David C., Goldstone, Anthony H., Mackinnon, Stephen

Source: In Blood 1 February 2002 99(3):1071-1078

The diagnosis and management of acute myeloid leukaemia

Authors: Milligan, Donald W ^*

Source: In Clinical Medicine September 2001 1(5):358-361

Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Authors: Auer, Rebecca L., Jones, Christopher, Mullenbach, Roman A., Syndercombe-Court, Denise, Milligan, Donald W., Fegan, Christopher D., Cotter, Finbarr E.

Source: In Blood 15 January 2001 97(2):509-515

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Authors: Kottaridis, Panagiotis D., Milligan, Donald W., Chopra, Rajesh, Chakraverty, Ronjon K., Chakrabarti, Suparno, Robinson, Stephen, Peggs, Karl, Verfuerth, Stephanie, Pettengell, Ruth, Marsh, Judith C.W., Schey, Stephen, Mahendra, Premini, Morgan, Gareth J., Hale, Geoff, Waldmann, Herman, de Elvira, M. Carmen Ruiz, Williams, Catherine D., Devereux, Stephen, Linch, David C., Goldstone, Anthony H., Mackinnon, Stephen ^*

Source: In Blood 1 October 2000 96(7):2419-2425

Secondary Leukaemia and Myelodysplasia after Autografting for Lymphoma: Is the Transplant to Blame?

Authors: Milligan, Donald W.

Source: Leukemia & Lymphoma. Oct2000, Vol. 39 Issue 3/4, p223. 6p.

Subject Terms: *LYMPHOMAS, *ACUTE leukemia, *STEM cell transplantation